172 related articles for article (PubMed ID: 28559011)
1. Protein tyrosine phosphatase σ regulates autoimmune encephalomyelitis development.
Ohtake Y; Kong W; Hussain R; Horiuchi M; Tremblay ML; Ganea D; Li S
Brain Behav Immun; 2017 Oct; 65():111-124. PubMed ID: 28559011
[TBL] [Abstract][Full Text] [Related]
2. CYBB/NOX2 in conventional DCs controls T cell encephalitogenicity during neuroinflammation.
Keller CW; Kotur MB; Mundt S; Dokalis N; Ligeon LA; Shah AM; Prinz M; Becher B; Münz C; Lünemann JD
Autophagy; 2021 May; 17(5):1244-1258. PubMed ID: 32401602
[TBL] [Abstract][Full Text] [Related]
3. Interferon-β regulates dendritic cell activation and migration in experimental autoimmune encephalomyelitis.
Pennell LM; Fish EN
Immunology; 2017 Nov; 152(3):439-450. PubMed ID: 28646573
[TBL] [Abstract][Full Text] [Related]
4. Inconsistence between number and function of autoreactive T cells in the course of experimental autoimmune encephalomyelitis.
Wan X; Pei W; Zhang Y; Zhang L; Shahzad KA; Xu T; Shen C
Immunol Invest; 2018 Jan; 47(1):1-17. PubMed ID: 28872930
[TBL] [Abstract][Full Text] [Related]
5. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L
Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934
[TBL] [Abstract][Full Text] [Related]
6. Persistent macrophage/microglial activation and myelin disruption after experimental autoimmune encephalomyelitis in tissue inhibitor of metalloproteinase-1-deficient mice.
Crocker SJ; Whitmire JK; Frausto RF; Chertboonmuang P; Soloway PD; Whitton JL; Campbell IL
Am J Pathol; 2006 Dec; 169(6):2104-16. PubMed ID: 17148673
[TBL] [Abstract][Full Text] [Related]
7. Resistance to experimental autoimmune encephalomyelitis and impaired T cell priming by dendritic cells in Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 mutant mice.
Tomizawa T; Kaneko Y; Kaneko Y; Saito Y; Ohnishi H; Okajo J; Okuzawa C; Ishikawa-Sekigami T; Murata Y; Okazawa H; Okamoto K; Nojima Y; Matozaki T
J Immunol; 2007 Jul; 179(2):869-77. PubMed ID: 17617577
[TBL] [Abstract][Full Text] [Related]
8. Induction of inhibitory central nervous system-derived and stimulatory blood-derived dendritic cells suggests a dual role for granulocyte-macrophage colony-stimulating factor in central nervous system inflammation.
Hesske L; Vincenzetti C; Heikenwalder M; Prinz M; Reith W; Fontana A; Suter T
Brain; 2010 Jun; 133(Pt 6):1637-54. PubMed ID: 20424288
[TBL] [Abstract][Full Text] [Related]
9. Selective depletion of CD11c
Wang L; Li Z; Ciric B; Safavi F; Zhang GX; Rostami A
Eur J Immunol; 2016 Oct; 46(10):2454-2466. PubMed ID: 27338697
[TBL] [Abstract][Full Text] [Related]
10. An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response.
Choi JH; Lee MJ; Jang M; Kim EJ; Shim I; Kim HJ; Lee S; Lee SW; Kim YO; Cho IH
PLoS One; 2015; 10(10):e0138592. PubMed ID: 26444423
[TBL] [Abstract][Full Text] [Related]
11. Protein tyrosine phosphatase receptor type z negatively regulates oligodendrocyte differentiation and myelination.
Kuboyama K; Fujikawa A; Masumura M; Suzuki R; Matsumoto M; Noda M
PLoS One; 2012; 7(11):e48797. PubMed ID: 23144976
[TBL] [Abstract][Full Text] [Related]
12. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
Zheng H; Zhang H; Liu F; Qi Y; Jiang H
Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
[TBL] [Abstract][Full Text] [Related]
13. Antigen-oriented T cell migration contributes to myelin peptide induced-EAE and immune tolerance.
Zheng P; Fu H; Wei G; Wei Z; Zhang J; Ma X; Rui D; Meng X; Ming L
Clin Immunol; 2016 Aug; 169():36-46. PubMed ID: 27327113
[TBL] [Abstract][Full Text] [Related]
14. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O
J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550
[TBL] [Abstract][Full Text] [Related]
15. [Myeloid-derived Gr-1⁺ CD11b⁺ suppressor cells are involved in immunoregulation of experimental autoimmune encephalomyelitis].
Wu F; Dang D; Guo J; Li H; Yang K; Zhao D; Guo P; Li Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug; 30(8):789-92, 797. PubMed ID: 25108427
[TBL] [Abstract][Full Text] [Related]
16. MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE.
Mony JT; Khorooshi R; Owens T
Mult Scler; 2014 Sep; 20(10):1312-21. PubMed ID: 24552747
[TBL] [Abstract][Full Text] [Related]
17. Influenza virus infection exacerbates experimental autoimmune encephalomyelitis disease by promoting type I T cells infiltration into central nervous system.
Chen Q; Liu Y; Lu A; Ni K; Xiang Z; Wen K; Tu W
J Autoimmun; 2017 Feb; 77():1-10. PubMed ID: 28341037
[TBL] [Abstract][Full Text] [Related]
18. Immune profile of an atypical EAE model in marmoset monkeys immunized with recombinant human myelin oligodendrocyte glycoprotein in incomplete Freund's adjuvant.
Jagessar SA; Heijmans N; Blezer EL; Bauer J; Weissert R; 't Hart BA
J Neuroinflammation; 2015 Sep; 12():169. PubMed ID: 26377397
[TBL] [Abstract][Full Text] [Related]
19. Absence of Notch1 in murine myeloid cells attenuates the development of experimental autoimmune encephalomyelitis by affecting Th1 and Th17 priming.
Fernández M; Monsalve EM; López-López S; Ruiz-García A; Mellado S; Caminos E; García-Ramírez JJ; Laborda J; Tranque P; Díaz-Guerra MJM
Eur J Immunol; 2017 Dec; 47(12):2090-2100. PubMed ID: 28762472
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine kinase 2 plays critical roles in the pathogenic CD4 T cell responses for the development of experimental autoimmune encephalomyelitis.
Oyamada A; Ikebe H; Itsumi M; Saiwai H; Okada S; Shimoda K; Iwakura Y; Nakayama KI; Iwamoto Y; Yoshikai Y; Yamada H
J Immunol; 2009 Dec; 183(11):7539-46. PubMed ID: 19917699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
